This episode breaks down the impact of the 340B Drug Pricing Program, a critical federal initiative reshaping the healthcare consolidation landscape. From rural clinics to large health systems, 340B is influencing everything from care delivery models to market consolidation. This conversation offers timely insights for healthcare systems and healthcare consumers into how financial incentives under 340B are redefining outpatient care and driving strategic decisions across the sector.